PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
Larry W Moreland Selected Research
TNFR-Fc fusion protein (etanercept)
05/2006
Etanercept treatment in adults with established rheumatoid arthritis: 7 years of clinical experience.
04/2006
Effect of etanercept on fatigue in patients with recent or established rheumatoid arthritis.
04/2006
Comparison of 2 doses of etanercept (50 vs 100 mg) in active rheumatoid arthritis: a randomized double blind study.
01/2006
Long-term experience with etanercept in the treatment of rheumatoid arthritis in elderly and younger patients: patient-reported outcomes from multiple controlled and open-label extension studies.
07/2005
Longterm safety, efficacy, and radiographic outcome with etanercept treatment in patients with early rheumatoid arthritis.
09/2004
The influence of genetic variation in the HLA-DRB1 and LTA-TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanercept.
08/2004
Etanercept (Enbrel) in patients with rheumatoid arthritis with recent onset versus established disease: improvement in disability.
04/2003
Response to etanercept (Enbrel) in elderly patients with rheumatoid arthritis: a retrospective analysis of clinical trial results.
06/2002
Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes.
Articles by Research Topic
Disease
26
Rheumatoid Arthritis
06/2008 - 03/2002
2
Gout
09/2008 - 12/2005
2
Osteoarthritis
07/2005 - 01/2003
1
Fatigue
04/2006
1
Knee Osteoarthritis
02/2006
1
Hyperuricemia
12/2005
1
Systemic Lupus Erythematosus (Libman-Sacks Disease)
09/2004
Drug/Important Bio-Agent (IBA)
9
TNFR-Fc fusion protein (etanercept)
FDA Link
05/2006 - 06/2002
8
Methotrexate (Mexate)
FDA Link
Generic
04/2008 - 03/2002
6
abatacept (BELATACEPT)
FDA Link
04/2008 - 06/2002
2
HLA-DRB1 antigen (HLA DRB1)
IBA
02/2008 - 09/2004
2
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
06/2003 - 01/2003
2
adalimumab (Humira)
FDA Link
06/2003 - 01/2003
1
Urate Oxidase (Uricase)
IBA
09/2008
1
Polyethylene Glycols (Polyethylene Glycol)
FDA Link
Generic
09/2008
1
Uric Acid (Urate)
IBA
09/2008
1
Antirheumatic Agents (DMARD)
IBA
06/2008
1
cyclic citrullinated peptide
IBA
09/2006
1
Rheumatoid Factor
IBA
09/2006
1
Chondroitin Sulfates (Chondroitin Sulfate)
IBA
02/2006
1
Glucosamine (Dona)
IBA
02/2006
1
febuxostat
IBA
12/2005
1
Doxycycline (Vibramycin)
FDA Link
Generic
07/2005
1
Dehydroepiandrosterone (DHEA)
IBA
09/2004
1
infliximab (Remicade)
FDA Link
01/2003
1
Hyaluronic Acid (Hyaluronan)
IBA
01/2003
1
Glucocorticoids
IBA
10/2002
1
Tacrolimus (Prograf)
FDA Link
08/2002
1
Hydroxychloroquine (Plaquenil)
FDA Link
Generic
06/2002
1
Interleukin 1 Receptor Antagonist Protein (Anakinra)
FDA Link
03/2002
1
Interleukin-1 (Interleukin 1)
IBA
03/2002
Therapy/Procedure
1
Biological Therapy
06/2004